Loading...
XNAS
BEAT
Market cap25mUSD
Dec 05, Last price  
0.73USD
1D
1.39%
1Q
-45.93%
Jan 2017
-96.73%
IPO
-98.99%
Name

Heartbeam Inc

Chart & Performance

D1W1MN
XNAS:BEAT chart
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
26.68%
Rev. gr., 5y
%
Revenues
0k
30,937,72833,922,80172,992,186120,454,000140,621,000119,924,000119,022,000111,494,000129,501,000166,578,000178,513,000208,332,000286,776,000399,472,000000000
Net income
-19m
L+32.85%
-11,463,257-7,644,732-358,0719,205,000-20,476,000-19,860,000-61,422,000-12,202,000-7,319,000-9,793,0007,428,00053,437,000-15,956,00042,820,000-778,000-1,348,000-6,593,000-12,827,000-14,639,000-19,448,000
CFO
-14m
L+19.66%
-2,912,729-237,63910,308,0007,904,00010,362,0005,030,0005,743,00011,259,0008,811,00014,350,00038,851,00023,782,00072,746,000-218,000-600,000-3,230,000-9,948,000-12,093,000-14,471,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
URL
https://www.heartbeam.com/
IPO date
Oct 14, 2021
Employees
10
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT